Hikal Stock Falls to 52-Week Low of Rs.225 Amidst Continued Downtrend

The stock has recorded a consecutive two-day fall, resulting in a cumulative return of -2.91% during this period. This decline contrasts with the broader market trend, as the Sensex closed higher by 0.58% at 85,162.68, edging closer to its own 52-week high of 85,290.06. Notably, Hikal underperformed its sector by 1.03% today, reflecting a divergence from the general market and sectoral strength.

Technical indicators reveal that Hikal is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests sustained downward pressure on the stock price over multiple time horizons.

Over the past year, Hikal’s stock has generated a return of -42.05%, a stark contrast to the Sensex’s 9.79% gain over the same period. The stock’s 52-week high was Rs.464.5, indicating a substantial decline from its peak. This underperformance extends beyond the last year, with the stock also lagging behind the BSE500 index over the last three years, one year, and three months.

From a fundamental perspective, the company’s long-term financial metrics highlight challenges. Operating profits have shown a compound annual growth rate (CAGR) of -16.24% over the last five years, indicating contraction in core earnings. The company’s ability to service debt is constrained, with a Debt to EBITDA ratio of 2.51 times, suggesting elevated leverage relative to earnings before interest, taxes, depreciation, and amortisation.

Profitability metrics also reflect subdued performance. The average Return on Equity (ROE) stands at 8.00%, signalling modest returns generated on shareholders’ funds. Recent quarterly results have been notably weak, with earnings per share (EPS) falling by -320.54% in the September 2025 quarter. The company reported a net loss after tax (PAT) of Rs. -34.90 crore for the quarter, a significant decline compared to the previous four-quarter average.

Return on Capital Employed (ROCE) for the half-year period was recorded at 4.44%, one of the lowest levels observed, while the operating profit to interest coverage ratio for the quarter was 0.48 times, indicating limited buffer to cover interest expenses from operating profits.

Despite these challenges, Hikal’s valuation metrics present a contrasting picture. The company’s ROCE of 4.1 and an enterprise value to capital employed ratio of 1.9 suggest that the stock is trading at a discount relative to its peers’ historical valuations. This valuation gap may reflect the market’s assessment of the company’s current financial and operational position.

Majority ownership of Hikal remains with promoters, maintaining a stable shareholding structure. However, the company’s recent financial performance and stock price trajectory highlight the pressures it faces within the Pharmaceuticals & Biotechnology sector.

In comparison, the broader market environment remains positive. The Sensex is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a bullish trend. Mega-cap stocks are leading the market gains, further underscoring the divergence between Hikal’s performance and the overall market momentum.

In summary, Hikal’s stock has reached a new 52-week low of Rs.225, reflecting a continuation of its downward trend amid subdued financial results and valuation adjustments. The stock’s performance contrasts with the broader market’s upward movement, underscoring sector-specific and company-specific factors influencing its price action.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →